The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Randomized, Placebo-Controlled Trial of Anticoagulant Treatment With Low-Molecular-Weight Heparin for Cerebral Sinus Thrombosis
Open accessAbstract
Background and Purpose —Treatment of cerebral sinus thrombosis with heparin is controversial. We conducted a double-blind, placebo-controlled multicenter trial to examine whether anticoagulant treatment improves outcome in patients with sinus thrombosis. Methods —Patients were randomized between body weight–adjusted subcutaneous nadroparin (180 anti–factor Xa units/kg per 24 hours) and matching placebo for 3 weeks (double-blind part of trial), followed by 3 months of oral anticoagulants for patients allocated nadroparin (open part). Patients with cerebral hemorrhage caused by sinus thrombosis were also included. Results —Sixty patients were enrolled, and none were lost to follow-up. In 1 patient the diagnosis proved wrong after randomization. After 3 weeks, 6 of 30 patients (20%) in the nadroparin group and 7 of 29 patients (24%) in the placebo group had a poor outcome, defined as death or Barthel Index score of <15 (risk difference, −4%; 95% CI, −25 to 17%; NS). After 12 weeks, 4 of 30 patients (13%) in the nadroparin group and 6 of 29 (21%) in the placebo group had a poor outcome, defined as death or Oxford Handicap Score of ≥3 (risk difference, −7%; 95% CI, −26% to 12%; NS). There were no new symptomatic cerebral hemorrhages. One patient in the nadroparin group had a major gastrointestinal hemorrhage, and 1 patient in the placebo group died from clinically suspected pulmonary embolism. Conclusions —Patients with cerebral sinus thrombosis treated with anticoagulants (low-molecular-weight heparin followed by oral anticoagulation) had a favorable outcome more often than controls, but the difference was not statistically significant. Anticoagulation proved to be safe, even in patients with cerebral hemorrhage.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
Interobserver agreement for the assessment of handicap in stroke patients
van Swieten, J. C., Koudstaal, P. J., Visser, M. C., Schouten, H. J., & van Gijn, J. (1988) · Stroke · doi:10.1161/01.str.19.5.604 · Cited by 6,512
Heparin treatment in sinus venous thrombosis
Einhäupl, K. M., Villringer, A., Mehraein, S., Garner, C., Pellkofer, M., Haberl, R. L., Pfister, H.-W., Schmiedek, P., & Meister, W. (1991) · The Lancet · doi:10.1016/0140-6736(91)90607-q · Cited by 992
Low-Molecular-Weight Heparin in the Treatment of Patients with Venous Thromboembolism
(1997) · New England Journal of Medicine · doi:10.1056/nejm199709043371001 · Cited by 784
Cerebral venous thrombosis--a review of 38 cases.
Bousser, M. G., Chiras, J., Bories, J., & Castaigne, P. (1985) · Stroke · doi:10.1161/01.str.16.2.199 · Cited by 778
Treatment of Deep Venous Thrombosis With Low-Molecular-Weight Heparins: A Meta-analysis
Lensing, A. W. A. (1995) · Archives of Internal Medicine · doi:10.1001/archinte.1995.00430060059007 · Cited by 285
Deschiens, M.-A., Conard, J., Horellou, M. H., Ameri, A., Preter, M., Chedru, F., Samama, M. M., & Bousser, M.-G. (1996) · Stroke · doi:10.1161/01.str.27.10.1724 · Cited by 276
Wells, P. S. (1994) · Archives of Internal Medicine · doi:10.1001/archinte.154.1.67 · Cited by 235
Low Molecular Weight Heparins (LMWH) in the Treatment of Patients with Acute Venous Thromboembolism
Hirsh, J., Siragusa, S., Cosmi, B., & Ginsberg, J. S. (1995) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1642702 · Cited by 71
Cited by
Kernan, W. N., Ovbiagele, B., Black, H. R., Bravata, D. M., Chimowitz, M. I., Ezekowitz, M. D., Fang, M. C., Fisher, M., Furie, K. L., Heck, D. V., et al. (2014) · Stroke · doi:10.1161/str.0000000000000024 · Cited by 5,170
Antithrombotic Therapy for VTE Disease
Kearon, C., Akl, E. A., Ornelas, J., Blaivas, A., Jimenez, D., Bounameaux, H., Huisman, M., King, C. S., Morris, T. A., Sood, N., et al. (2016) · Chest · doi:10.1016/j.chest.2015.11.026 · Cited by 4,830
Ferro, J. M., Canhão, P., Stam, J., Bousser, M.-G., & Barinagarrementeria, F. (2004) · Stroke · doi:10.1161/01.str.0000117571.76197.26 · Cited by 2,315
Self-citationSaposnik, G., Barinagarrementeria, F., Brown, R. D., Bushnell, C. D., Cucchiara, B., Cushman, M., deVeber, G., Ferro, J. M., & Tsai, F. Y. (2011) · Stroke · doi:10.1161/str.0b013e31820a8364 · Cited by 1,970
Sacco, R. L., Adams, R., Albers, G., Alberts, M. J., Benavente, O., Furie, K., Goldstein, L. B., Gorelick, P., Halperin, J., Harbaugh, R., et al. (2006) · Stroke · doi:10.1161/01.str.0000199147.30016.74 · Cited by 1,873
Metadata
- Authors
- de Bruijn, S. F. T. M., & Stam, J.
- Venue
- Stroke
- Published
- 1999-03
- Volume
- 30
- Issue
- 3
- Pages
- 484-488
- ISSN
- 0039-2499 (ISSN-L)
- 1524-4628
- OpenAlex
- W2171119585
- Cited by
- 817
- References
- 9
- FWCI
- 19.57
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.